Abilify (aripiprazole) is an atypical antipsychotic used to treat a range of psychiatric conditions including bipolar disorder, schizophrenia, major depressive disorder (as an add-on to antidepressants), and irritability associated with autism. Unlike older antipsychotics, Abilify works as a partial dopamine agonist — meaning it modulates dopamine activity rather than simply blocking it — which generally produces a different and often more tolerable side effect profile. At Elevate Psychiatry, we prescribe Abilify when the clinical situation warrants it and monitor closely for side effects throughout treatment.
The most common side effects include restlessness or akathisia (an inner feeling of needing to move), insomnia, headache, nausea, constipation, lightheadedness, and drowsiness. Akathisia deserves special attention because it can be intensely uncomfortable — patients describe it as an irresistible urge to move, pace, or shift position. It occurs in approximately 10-15% of patients and is dose-dependent. If you experience akathisia, contact your psychiatrist promptly — dose adjustment, adding a beta-blocker, or switching medications can provide relief.
Abilify is generally considered one of the more weight-neutral atypical antipsychotics — it causes less weight gain than quetiapine (Seroquel) or olanzapine. However, "less" does not mean "none." Some patients do experience weight gain, increased appetite, and metabolic changes including elevated blood sugar and cholesterol. Regular monitoring of weight, fasting glucose, and lipid panels is recommended during treatment, particularly in the first few months and annually thereafter.
As with all antipsychotics, Abilify carries a risk of movement disorders including tardive dyskinesia (involuntary, repetitive movements — typically of the face and tongue). The risk with Abilify is lower than with older antipsychotics but is not zero, and increases with duration of treatment and higher doses. Extrapyramidal symptoms (stiffness, tremor, involuntary movements) can also occur, though less frequently than with first-generation antipsychotics. Any new involuntary movements should be reported to your psychiatrist immediately.
A unique and important side effect of Abilify is the potential for impulse control problems — compulsive gambling, shopping, eating, or sexual behavior. This is thought to relate to its partial dopamine agonist mechanism, which can overstimulate reward pathways in susceptible individuals. These behaviors may be out of character for the patient and can cause significant harm before being recognized as medication-related. If you or someone close to you notices new compulsive behaviors after starting Abilify, report them to your psychiatrist promptly.
If you are experiencing side effects from Abilify or want to discuss whether it is the right medication for your condition, schedule an appointment with Elevate Psychiatry. We offer in-person care in Miami and virtual visits throughout Florida.
For patients who cannot tolerate the metabolic effects of atypical antipsychotics, lamotrigine is a well-tolerated mood stabilizer alternative for bipolar depression prevention.
This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
